Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Routine coagulation tests are not useful as a screening tool for the FII G20210A polymorphism.

Clinical laboratory - 1 Jan 2014

Rolla Roberta, Pergolini Patrizia, Vidali Matteo, Pollarolo Paola, Appiani Alice, Cerutti Chiara, Manzini Matteo, Crisci Alice, Bellomo Giorgio

Abstract excerpt

BACKGROUND: The identification of prothrombin G20210A polymorphism (PT20210) is normally included in the thrombophilia laboratory panel and evaluated by DNA-based molecular analysis. To date, a routine coagulation test that helps to identify PT20210 carriers has not been set, in contrast to the FV Leiden mutation, for which a functional coagulation test, the Activated Protein C Resistance test (APCR), is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation
Share to Blood Coagulation Tests

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to International Normalized Ratio

Share to Partial Thromboplastin Time

Share to Predictive Value of Tests

Share to Prothrombin

Share to Prothrombin Time

Share to Thrombophilia

Source

Identifiers

PMID: 25651720
DOI: 10.7754/clin.lab.2014.140215

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Routine coagulation tests are not useful as a screening tool for the FII G20210A polymorphism.PMID 25651720Read ↗

Prothrombin activity and concentration in healthy subjects with and without the prothrombin G20210A mutation.Semantic proximity Read ↗

Thrombophilia Screening: Not So StraightforwardSemantic proximity Read ↗

[G20210A transition in the prothrombin gene and venous thromboembolic disease].Semantic proximity Read ↗

Comparative evaluation of five different methods for the measurement of plasma factor II levels in carriers of the 20210A prothrombin variant.Semantic proximity Read ↗

Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance.Semantic proximity Read ↗

Analysis of factor V Leiden and prothrombin mutations in patients with suspected thrombophilia in São Paulo state-BrazilSemantic proximity Read ↗

Clinical and Molecular Study of Common Thrombophilia Mutation Prothrombin G20210A.Semantic proximity Read ↗

Congenital prothrombin defects: they are not only associated with bleeding but also with thrombosis: a new classification is needed.Semantic proximity Read ↗

What is the clinical relevance of the prothrombin G20210A mutation?Semantic proximity Read ↗

Reliable genotyping of the G-20210-A mutation of coagulation factor II (prothrombin).Semantic proximity Read ↗

Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.Semantic proximity Read ↗

Prothrombin time, activated partial thromboplastin time and dilute Russell's Viper Venom times are not shorter in patients with the prothrombin G20210A mutation, and dilute Russell's Viper Venom time may be longer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.